News
A key weight-loss drug goes off-patent next year. A US study estimates its production cost to be less than 2% of its selling ...
A WOMAN has shared the brutally honest truth about what happened when she was forced to ”go cold turkey” from Mounjaro.
Tonight’s Hot Topic Tuesday revisits injectable weight-loss drugs and the new discoveries coming out about the medications.
GoodRx reports on identifying real Wegovy pens, which come in five colors and lack dose selectors. Counterfeits pose health ...
Some people are discovering that being thinner can sometimes mean looking older. Local cosmetic surgeons weigh-in with ...
The lawsuit said the union’s health plan allowed coverage of Xenical to treat obesity but not newer products such as Wegovy ...
Novo Nordisk sees 65% obesity drug sales growth, forecasts $8.14–$9.59B FY25 free cash flow. Click here to read an analysis ...
A new study from Mass Eye and Ear suggests that people taking semaglutide, a drug sold as Ozempic and Wegovy, may have a ...
Companies are selling personalized compounded drugs that combine weight loss and erectile dysfunction treatments, but is this safe? No one can say because it’s all “personalized” compounded drugs ...
Patients put on weight loss drugs like Ozempic and Wegovy may start regaining weight within weeks of discontinuing them, a ...
According to a recent study, nearly three in four Americans are overweight. Worse, this report predicts that for decades to ...
With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results